Skip to content
10-Q

Quarterly Report

JRSIS HEALTH CARE CORPORATION JRSS

0001213900-24-111011

← back to feed
Filed
Dec 20, 2024 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2024 · Dec 20, 2024 84.6M sh
Shares Diluted Q3 2024 · Sep 30, 2024 84.6M sh
Shares Diluted Q3 2024 · Sep 30, 2024 84.51M sh
Shares Diluted restated Q3 2024 · Sep 30, 2023 76.76M sh
Shares Diluted restated Q3 2024 · Sep 30, 2023 76.76M sh
Operating Cash Flow Q3 2024 · Sep 30, 2024 −$826.06K
Operating Cash Flow restated Q3 2024 · Sep 30, 2023 $420.97K
Long Term Debt Q3 2024 · Sep 30, 2024 $6.31K
Long Term Debt Q3 2024 · Dec 31, 2023 $24.95K
Short Term Debt Q3 2024 · Sep 30, 2024 $1.31M
Short Term Debt Q3 2024 · Dec 31, 2023 $983.01K
Stockholders Equity Q3 2024 · Sep 30, 2024 −$197.59K
Stockholders Equity Q3 2024 · Dec 31, 2023 −$137.41K
Current Liabilities Q3 2024 · Sep 30, 2024 $2.3M
Current Liabilities Q3 2024 · Dec 31, 2023 $2.28M
Total Liabilities Q3 2024 · Sep 30, 2024 $2.31M
Total Liabilities Q3 2024 · Dec 31, 2023 $2.31M
Current Assets Q3 2024 · Sep 30, 2024 $1.79M
Current Assets Q3 2024 · Dec 31, 2023 $1.83M
Total Assets Q3 2024 · Sep 30, 2024 $2.07M
Total Assets Q3 2024 · Dec 31, 2023 $2.14M
Eps Diluted Q3 2024 · Sep 30, 2024 −$0.00
Eps Diluted Q3 2024 · Sep 30, 2024 −$0.01
Eps Diluted restated Q3 2024 · Sep 30, 2023 $0.00
Eps Diluted restated Q3 2024 · Sep 30, 2023 −$0.00
Eps Basic Q3 2024 · Sep 30, 2024 −$0.00
Eps Basic Q3 2024 · Sep 30, 2024 −$0.01
Eps Basic restated Q3 2024 · Sep 30, 2023 $0.00
Eps Basic restated Q3 2024 · Sep 30, 2023 −$0.00
Sga Expense Q3 2024 · Sep 30, 2024 $97.36K
Sga Expense Q3 2024 · Sep 30, 2024 $384.96K
Sga Expense Q3 2024 · Sep 30, 2023 $22.54K
Sga Expense Q3 2024 · Sep 30, 2023 $172.57K
Rd Expense Q3 2024 · Sep 30, 2024 $28.84K
Rd Expense Q3 2024 · Sep 30, 2024 $48.69K
Rd Expense Q3 2024 · Sep 30, 2023 $36.2K
Rd Expense Q3 2024 · Sep 30, 2023 $104.84K
Net Income Q3 2024 · Sep 30, 2024 −$188.15K
Net Income Q3 2024 · Sep 30, 2024 −$435.94K
Net Income restated Q3 2024 · Sep 30, 2023 $33.71K
Net Income restated Q3 2024 · Sep 30, 2023 −$26.87K
Operating Income Q3 2024 · Sep 30, 2024 −$206.19K
Operating Income Q3 2024 · Sep 30, 2024 −$485.81K
Operating Income restated Q3 2024 · Sep 30, 2023 $51.01K
Operating Income restated Q3 2024 · Sep 30, 2023 $1.25K
Gross Profit Q3 2024 · Sep 30, 2024 $26.89K
Gross Profit Q3 2024 · Sep 30, 2024 $270.22K
Gross Profit Q3 2024 · Sep 30, 2023 $120.11K
Gross Profit Q3 2024 · Sep 30, 2023 $311.11K
Cost Of Revenue Q3 2024 · Sep 30, 2024 $196.04K
Cost Of Revenue Q3 2024 · Sep 30, 2024 $1.05M
Cost Of Revenue Q3 2024 · Sep 30, 2023 $377.25K
Cost Of Revenue Q3 2024 · Sep 30, 2023 $1M
Revenue Q3 2024 · Sep 30, 2024 $222.92K
Revenue Q3 2024 · Sep 30, 2024 $1.32M
Revenue restated Q3 2024 · Sep 30, 2023 $497.36K
Revenue restated Q3 2024 · Sep 30, 2023 $1.31M
Capex Q3 2024 · Sep 30, 2023 $249